×

本司产品仅用于科研,不用于临床诊断和治疗

全国免费热线:400-999-2100

您身边的细胞培养专家!

所有分类
  • 所有分类
  • 细胞系
  • 原代细胞
  • 血清
  • 细胞培养基
  • 辅助试剂
  • 细胞凋亡检测试剂盒
  • 细胞房除菌产品
热搜: 胎牛血清 VERO RAW264.7 成纤维细胞 间充质干细胞 上皮细胞

忘记密码

个人邮箱:
验证码: captcha

账号激活

个人邮箱:
×
当前位置:首页 >> 产品中心 >> 细胞资源库 >> 细胞系 >> 

产品中心Cell Resources

联系我们CONTACT US

  • SK-OV-3 (人卵巢癌细胞) (STR鉴定正确)
  • SK-OV-3 (人卵巢癌细胞) (STR鉴定正确)
  • SK-OV-3 (人卵巢癌细胞) (STR鉴定正确)
  • SK-OV-3 (人卵巢癌细胞) (STR鉴定正确)
  • SK-OV-3 (人卵巢癌细胞) (STR鉴定正确)
  • SK-OV-3 (人卵巢癌细胞) (STR鉴定正确)
  • SK-OV-3 (人卵巢癌细胞) (STR鉴定正确)

SK-OV-3 (人卵巢癌细胞) (STR鉴定正确)

货号:CL-0215

规格:1×10⁶cells/T25培养瓶

价格: ¥1600

生长培养基:McCoy's 5A10% FBS1% P/S

数量: - +

  • SK-OV-3 (人卵巢癌细胞) (STR鉴定正确)
  • SK-OV-3 (人卵巢癌细胞) (STR鉴定正确)
  • SK-OV-3 (人卵巢癌细胞) (STR鉴定正确)
  • SK-OV-3 (人卵巢癌细胞) (STR鉴定正确)
  • SK-OV-3 (人卵巢癌细胞) (STR鉴定正确)
  • SK-OV-3 (人卵巢癌细胞) (STR鉴定正确)
  • SK-OV-3 (人卵巢癌细胞) (STR鉴定正确)

推荐搭配

套餐1:

SK-OV-3 (人卵巢癌细胞) (STR鉴定正确) ¥1600
SK-OV-3细胞专用培养基
  • ¥350
  • ¥500

现单独购买该产品也可享受限时优惠价!

细胞培养最优解!

套餐组合价:¥1950¥2100

加入购物车

搭配套餐已成功加入购物车!

产品概述
产品信息
名称 SK-OV-3 (人卵巢癌细胞) (STR鉴定正确)
别称 SKOV-3; SK.OV.3; SKOV3; Skov3; SKO3
种属
生长特性 贴壁细胞
细胞形态 上皮细胞样
冻存条件 冻存液:55% 基础培养基+40%FBS+5%DMSO 温度:液氮
培养方案A(默认)
生长培养基:
培养条件:
气相:空气,95%;CO2,5%, 温度:37℃
推荐传代比例 1:2-1:4
推荐换液频率 2-3次/周
参考资料(来源文献)
背景描述 SK-OV-3细胞是由G·Trempe和L·J·Old于1973年从卵巢肿瘤病人的腹水分离得到。SK-OV-3细胞对肿瘤坏死因子和几种细胞毒性药物包括白喉毒素、顺铂和阿霉素均耐受。SK-OV-3细胞在裸鼠中致瘤,且形成与卵巢原位癌一致的中度分化的腺癌。
年龄(性别) 女性;64岁
组织来源 卵巢腺癌,腹水转移
细胞类型 肿瘤细胞
肿瘤类型 卵巢癌细胞
生物安全等级 BSL-1
倍增时间 ~20-48 hours
致瘤性 Yes, in nude mice; forms moderately well differentiated adenocarcinoma consistent with ovarian primary.
抗原表达情况 Blood Type B; Rh+
基因表达情况 Blood Type B; Rh+
保藏机构 ATCC; HTB-77 ECACC; 91091004
STR鉴定
  • STR位点信息
    Amelogenin X
    CSF1PO 11
    D2S1338 18,23
    D3S1358 14
    D5S818 11
    D7S820 13,14
    D8S1179 14,15
    D13S317 8,11
    D16S539 12
    D18S51 16,17,18
    D19S433 14,14.2
    D21S11 30,31.2
    FGA 24,25
    PentaD 12,13
    PentaE 5,13
    TH01 9,9.3
    TPOX 7,8,11
    vWA 17,18
    D6S1043 12
    D12S391 22
    D2S441 10,11.3
  • STR鉴定图
参考文献
文献列表
  • A smart O2-generating nanocarrier optimizes drug transportation comprehensively for chemotherapy improving(2021/03/29)

    作者:Xiaojuan Zhang, Chuanchuan He, Yun Sun

    期刊:Acta Pharmaceutica Sinica B

    DOI:10.1016/j.apsb.2021.04.021

    影响因子 :14.500

    引用产品:CL-0215

  • Loss of SMURF2 expression enhances RACK1 stability and promotes ovarian cancer progression(2023/10/12)

    作者:Yanan Pi, Qiushi Feng, Fusheng Sun

    期刊:CELL DEATH AND DIFFERENTIATION

    DOI:10.1038/s41418-023-01226-w

    影响因子 :12.400

    引用产品:CL-0215

  • Elevated expression of the rhythm gene NFIL3 promotes the progression of TNBC by activating NF-κB signaling through suppression of NFKBIA transcription(2022/02/18)

    作者:Weiwei Yang , Jing Li, Minghui Zhang

    期刊:Journal Of Experimental & Clinical Cancer Research

    DOI:10.1186/s13046-022-02260-1

    影响因子 :11.300

    引用产品:CL-0016 CL-0041 CL-0097 CL-0101 CL-0114 CL-0184 CL-0215 CL-0525

  • MiR-337–3p suppresses proliferation of epithelial ovarian cancer bytargeting PIK3CA and PIK3CB(2019/10/17)

    作者:Zhen Zhang, Luoyan Zhang, Bin Wang

    期刊:Cancer Letters

    DOI:10.1016/j.canlet.2019.10.021

    影响因子 :9.700

    引用产品:CL-0005 CL-0079 CL-0178 CL-0215

  • A solid lipid coated calcium peroxide nanocarrier enables combined cancer chemo/chemodynamic therapy with O2/H2O2 self-sufficiency(2021/1/6)

    作者:Chuanchuan He, Xiaojuan Zhang, Chen Chen

    期刊:Acta Biomaterialia

    DOI:10.1016/j.actbio.2020.12.036

    影响因子 :9.300

    引用产品:CL-0215

  • Combination of Chemotherapy and Photodynamic Therapy with Oxygen Self-Supply in the Form of Mutual Assistance for Cancer Therapy(2021/05/28)

    作者:Ying Chen, Lei Zhang, Fangxuan Li

    期刊:International Journal of Nanomedicine

    DOI:10.2147/IJN.S298146

    影响因子 :8.000

    引用产品:CL-0215

  • IR780-loaded folate-targeted nanoparticles for near-infrared fluorescence image-guided surgery and photothermal therapy in ovarian cancer(2019/04/18)

    作者:Jiao Song, Ni Zhang, Liang Zhang

    期刊:International Journal of Nanomedicine

    DOI:10.2147/IJN.S203108

    影响因子 :8.000

    引用产品:CL-0215

  • Tumor-secreted anterior gradient-2 binds to VEGF and FGF2 and enhances their activities by promoting their homodimerization(2017/05/08)

    作者:H Guo, Q Zhu, X Yu

    期刊:Oncogene

    DOI:10.1038/onc.2017.132

    影响因子 :8.000

    引用产品:CL-0079 CL-0149 CL-0215

  • Diterpenoid honatisine overcomes temozolomide resistance in glioblastoma by inducing mitonuclear protein imbalance through disruption of TFAM-mediated mtDNA transcription(2023/12/29)

    作者:Zongyang Li, Ke Sai, Guoxu Ma

    期刊:PHYTOMEDICINE

    DOI:10.1016/j.phymed.2023.155328

    影响因子 :7.900

    引用产品:CL-0215

  • Toosendanin reduces cisplatin resistance in ovarian cancer through modulating the miR-195/ERK/β-catenin pathway(2022/11/25)

    作者:Ge Wang, Lu Li, Yan Li, Li-Hong Zhang

    期刊:PHYTOMEDICINE

    DOI:10.1016/j.phymed.2022.154571

    影响因子 :7.900

    引用产品:CL-0215 P-CA-201 P-CA-207

  • Isothiocyanate Iberin inhibits cell proliferation and induces cell apoptosis in the progression of ovarian cancer by mediating ROS accumulation and GPX1 expression(2021/06/17)

    作者:Tingting Gong, Qian Guo, Xiao Li

    期刊:Biomedicine & Pharmacotherapy

    DOI:10.1016/j.biopha.2021.111533

    影响因子 :7.500

    引用产品:CL-0178 CL-0215 PM150110 PM150710

  • A novel estrogen-targeted PEGylated liposome co-delivery oxaliplatin and paclitaxel for the treatment of ovarian cancer(2023/01/30)

    作者:Yizhuo Xie, Zhihui Ren, Hongyu Chen

    期刊:BIOMEDICINE & PHARMACOTHERAPY

    DOI:10.1016/j.biopha.2023.114304

    影响因子 :7.500

    引用产品:CL-0215

  • An Activity-Based Fluorogenic Probe Enables Cellular and in Vivo Profiling of Carboxylesterase Isozymes(2020/07/07)

    作者:Shiyu Liu, Renyu Qu, Rongrong Li

    期刊:Analytical Chemistry

    DOI:10.1021/acs.analchem.0c01554

    影响因子 :7.400

    引用产品:CL-0101 CL-0103 CL-0215

  • m6A methylation-mediated regulation of LncRNA MEG3 suppresses ovarian cancer progression through miR-885-5p and the VASH1 pathway(2024/01/29)

    作者:Yan Li, Shenghan Lou, Jian Zhang

    期刊:Journal of Translational Medicine

    DOI:10.1186/s12967-024-04929-x

    影响因子 :7.400

    引用产品:CL-0215

  • The application of HER2 and CD47 CAR-macrophage in ovarian cancer(2023/09/22)

    作者:Yizhao Chen, Xiangling Zhu, Hanze Liu

    期刊:Journal of Translational Medicine

    DOI:10.1186/s12967-023-04479-8

    影响因子 :7.400

    引用产品:CL-0215 CL-0233

  • Oncogenic microRNA-181d binding to OGT contributes to resistance of ovarian cancer cells to cisplatin(2021/12/08)

    作者:Wei Huang, Ling Chen, Kean Zhu

    期刊:Cell Death Discovery

    DOI:10.1038/s41420-021-00715-6

    影响因子 :7.000

    引用产品:CL-0215

  • Knockdown of long non-coding RNA HOTAIR reverses cisplatin resistance of ovarian cancer cells through inhibiting miR-138-5p-regulated EZH2 and SIRT1(2020/4/29)

    作者:Yun Zhang, Hao Ai, Xue Fan

    期刊:Biological Research

    DOI:10.1186/s40659-020-00286-3

    影响因子 :6.700

    引用产品:CL-0215

  • Co-encapsulation of (−)-epigallocatechin-3-gallate and piceatannol/oxyresveratrol in β-lactoglobulin: effect of ligand–protein binding on the antioxidant activity, stability, solubility and cytotoxicity(2021/06/02)

    作者:Tingting Liu, Min Liu, He Liu

    期刊:Food & Function

    DOI:10.1039/D1FO00481F

    影响因子 :6.317

    引用产品:CL-0215

  • Wenshenyang recipe treats infertility through hormonal regulation and inflammatory responses revealed by transcriptome analysis and network pharmacology(2022/08/08)

    作者:Lan Xie, Shuai Zhao, Xiaoling Zhang

    期刊:Frontiers in Pharmacology

    DOI:10.3389/fphar.2022.917544

    影响因子 :5.600

    引用产品:CL-0215

  • Identification of prognostic and diagnostic signatures for cancer and acute myocardial infarction: multi-omics approaches for deciphering heterogeneity to enhance patient management(2023/09/14)

    作者:Na Yuan, Haihua Pan, Yanshan Liang

    期刊:Frontiers in Pharmacology

    DOI:10.3389/fphar.2023.1249145

    影响因子 :5.600

    引用产品:CL-0215 CP-H055

  • The anticancer effect of extract of medicinal mushroom Sanghuangprous vaninii against human cervical cancer cell via endoplasmic reticulum stress-mitochondrial apoptotic pathway(2021/6/17)

    作者:Pingya He, Yuhao Hou, Yue Yang

    期刊:Journal Of Ethnopharmacology

    DOI:10.1016/j.jep.2021.114345

    影响因子 :5.400

    引用产品:CL-0210 CL-0215

  • Signatures of tumor-associated macrophages correlate with treatment response in ovarian cancer patients(2024/01/03)

    作者:Yang Gao, Yuwen Qi, Yin Shen

    期刊:Aging-US

    DOI:10.18632/aging.205362

    影响因子 :5.200

    引用产品:CL-0215

  • P76RBE silencing inhibits ovarian cancer cell proliferation, migration, and invasion via suppressing the integrin β1/NF-κB pathway(2021/08/12)

    作者:Limei Yan, Zeping He, Wei Li

    期刊:Cell Cycle

    DOI:10.1080/15384101.2021.1963910

    影响因子 :5.173

    引用产品:CL-0178 CL-0215 CM-0178 CM-0626 CM-H055 CP-H055

  • Knockdown of lncRNA ACTA2-AS1 reverses cisplatin resistance of ovarian cancer cells via inhibition of miR-378a-3p-regulated Wnt5a(2022/04/12)

    作者:Chenxiao Lin, Meiyun Zheng, Youlin Yang

    期刊:Bioengineered

    DOI:10.1080/21655979.2022.2061181

    影响因子 :4.900

    引用产品:CL-0215

  • Circular RNA lysophosphatidic acid receptor 3 (circ-LPAR3) enhances the cisplatin resistance of ovarian cancer(2022/01/26)

    作者:Xuemei Liu, Zhiping Yin, Yanjun Wu

    期刊:Bioengineered

    DOI:10.1080/21655979.2022.2029109

    影响因子 :4.900

    引用产品:CL-0215 CM-0013 CM-0215 CM-0524 CM-0654

  • MiR-29c downregulates tumor-expressed B7-H3 to mediate the antitumor NK-cell functions in ovarian cancer(2021/04/17)

    作者:Mengqi Deng, Di Wu, Yanqin Zhang

    期刊:Gynecologic Oncology

    DOI:10.1016/j.ygyno.2021.04.013

    影响因子 :4.700

    引用产品:CL-0079 CL-0178 CL-0215 CP-H055

  • Therapeutic potential of miRNAs in placental extracellular vesicles in ovarian and endometrial cancer(2023/10/06)

    作者:Yi Zhang, Yunhui Tang, Xinyue Chen

    期刊:Human Cell

    DOI:10.1007/s13577-023-00986-4

    影响因子 :4.300

    引用产品:CL-0215

  • CircLNPEP promotes the progression of ovarian cancer through regulating miR-876-3p/ WNT5A axis(2021/08/31)

    作者:Wenwen Wang, Weiwei Zhang, Hongjun Guo

    期刊:Cell Cycle

    DOI:10.1080/15384101.2021.1965723

    影响因子 :4.300

    引用产品:CL-0178 CL-0211 CL-0215

  • The role of OIP5 in the carcinogenesis and progression of ovarian cancer(2023/09/02)

    作者:Xin Zhang, Wenjie Gu, Aiqin Lin

    期刊:Journal of Ovarian Research

    DOI:10.1186/s13048-023-01265-4

    影响因子 :4.000

    引用产品:CL-0215 CP-H055

  • Knockdown of heat shock protein family D member 1 (HSPD1) promotes proliferation and migration of ovarian cancer cells via disrupting the stability of mitochondrial 3-oxoacyl-ACP synthase (OXSM)(2023/04/22)

    作者:Yaoyun Duan, Juan Yu, Miaojuan Chen

    期刊:Journal of Ovarian Research

    DOI:10.1186/s13048-023-01156-8

    影响因子 :4.000

    引用产品:CL-0079 CL-0178 CL-0215

  • CircSETDB1 knockdown inhibits the malignant progression of serous ovarian cancer through miR-129-3p-dependent regulation of MAP3K3(2021/11/17)

    作者:Bo Li, Lu Zhang

    期刊:Journal of Ovarian Research

    DOI:10.1186/s13048-021-00875-0

    影响因子 :4.000

    引用产品:CL-0005 CL-0215 CP-H055

  • Curcumin inhibits ovarian cancer progression by regulating circ-PLEKHM3/miR-320a/SMG1 axis(2021/11/16)

    作者:Sifan Sun, Hailiang Fang

    期刊:Journal of Ovarian Research

    DOI:10.1186/s13048-021-00916-8

    影响因子 :4.000

    引用产品:CL-0005 CL-0215

  • RNA-binding protein IGF2BP2 enhances circ_0000745 abundancy and promotes aggressiveness and stemness of ovarian cancer cells via the microRNA-3187-3p/ERBB4/PI3K/AKT axis(2021/11/13)

    作者:Shengtan Wang, Zaihong Li , Genhai Zhu

    期刊:Journal of Ovarian Research

    DOI:10.1186/s13048-021-00917-7

    影响因子 :4.000

    引用产品:CL-0079 CL-0215

  • Long non-coding RNA SNHG25 promotes epithelial ovarian cancer progression by up-regulating COMP(2021/1/16)

    作者:Yinglei Liu, Boqun Xu, Manhua Liu 

    期刊:Journal of Cancer

    DOI:10.7150/jca.47344

    影响因子 :3.900

    引用产品:CL-0215

  • MAPRE3 as an epigenetic target of EZH2 restricts ovarian cancer proliferation in vitro and in vivo(2024/01/08)

    作者:Yun Zhang, Fanglin Liu, Jindan Zheng

    期刊:EXPERIMENTAL CELL RESEARCH

    DOI:10.1016/j.yexcr.2024.113913

    影响因子 :3.700

    引用产品:CL-0215

  • Revealing the inhibitory effect of VASH1 on ovarian cancer from multiple perspectives(2023/11/27)

    作者:Yan Li, Liang Meng, Ge Lou

    期刊:CANCER BIOLOGY & THERAPY

    DOI:10.1080/15384047.2023.2285817

    影响因子 :3.600

    引用产品:CL-0215

  • Ovarian carcinoma immune-related microRNA affects the heterogeneity of the endocrine microenvironment and anti-tumor immune pattern(2023/10/09)

    作者:Kefei Gao, Qing Wang, Pan Xiang

    期刊:JOURNAL OF GENE MEDICINE

    DOI:10.1002/jgm.3602

    影响因子 :3.500

    引用产品:CL-0215

  • miR‑576‑3p overexpression enhances cisplatin sensitivity of ovarian cancer cells by dysregulating PD‑L1 and cyclin D1(2020/11/23)

    作者:Ying Zuo, Wei Zheng, Qing Tang

    期刊:Molecular Medicine Reports

    DOI:10.3892/mmr.2020.11719

    影响因子 :3.400

    引用产品:CL-0215

  • LPA3 is a precise therapeutic target and potential biomarker for ovarian cancer(2022/01/04)

    作者:Pengfei Zhao, Qingru Yun, Aodungerile Li

    期刊:Medical Oncology

    DOI:10.1007/s12032-021-01616-5

    影响因子 :3.400

    引用产品:CL-0215

  • Antiovarian cancer mechanism of esculetin: inducing G0/G1 arrest and apoptosis via JAK2/STAT3 signalling pathway(2022/11/04)

    作者:Yin Wen, Fu Xu, Chang Wenwen, Han Li, Meng Jiahao, Cao Aijia, Ren Xiaomin, Fan Zhongxiong, Zhou Suqin

    期刊:Journal of Pharmacy and Pharmacology

    DOI:10.1093/jpp/rgac083

    影响因子 :3.300

    引用产品:CL-0215

  • Screening of CXC chemokines in the microenvironment of ovarian cancer and the biological function of CXCL10(2021/11/18)

    作者:Weiyuan Li, Ji-ao Ma, Xun Sheng

    期刊:World Journal of Surgical Oncology

    DOI:10.1186/s12957-021-02440-x

    影响因子 :3.200

    引用产品:CL-0215

  • Norcantharidin induces ferroptosis via the suppression of NRF2/HO‑1 signaling in ovarian cancer cells(2022/08/25)

    作者:Xiaoyan Zhu, Xiaohong Chen, Longshan Qiu

    期刊:Oncology Letters

    DOI:10.3892/ol.2022.13479

    影响因子 :2.900

    引用产品:CL-0178 CL-0215

  • ARID5B promoted the histone demethylation of SORBS2 and hampered the metastasis of ovarian cancer(2023/11/03)

    作者:Yue Deng, Ying Dong, Lu Wu

    期刊:PATHOLOGY RESEARCH AND PRACTICE

    DOI:10.1016/j.prp.2023.154911

    影响因子 :2.800

    引用产品:CL-0215

  • Comparative proteomic analysis of the mitochondria of menstrual stem cells and ovarian cancer cells(2023/01/16)

    作者:Xiuhui Chen, Wen Zhong, Yue Chang

    期刊:Experimental and Therapeutic Medicine

    DOI:10.3892/etm.2023.11798

    影响因子 :2.700

    引用产品:CL-0215

  • The Antitumor Potential of Extract of the Oak Bracket Medicinal Mushroom Inonotus baumii in SMMC-7721 Tumor Cells(2019/9/22)

    作者:Yue Yang, Pingya He, Ning Li

    期刊:Evidence-based Complementary and Alternative Medicine

    DOI:10.1155/2019/1242784

    影响因子 :2.650

    引用产品:CL-0014 CL-0215 CL-0238

  • The Antitumor Potential of Extract of the Oak Bracket Medicinal Mushroom Inonotus baumii in SMMC-7721 Tumor Cells(2019/09/22)

    作者:Yue Yang, Pingya He

    期刊:Evidence-Based Complementary and Alternative Medicine

    DOI:10.1155/2019/1242784

    影响因子 :2.650

    引用产品:CL-0215

  • Circ_0021573 acts as a competing endogenous RNA to promote the malignant phenotypes of human ovarian cancer cells(2022/12/05)

    作者:Lifang Liu, Bingkai Han, Lixia Liu

    期刊:Reproductive Biology

    DOI:10.1016/j.repbio.2022.100704

    影响因子 :2.100

    引用产品:164210 164210-50 CL-0005 CL-0079 CL-0178 CL-0215 PB180120 PM150110

  • A morpholine derivative N-(4-morpholinomethylene)ethanesulfonamide induces ferroptosis in tumor cells by targeting NRF2(2024/01/30)

    作者:Bingchun Sun, Ligang Zhang, Binhua Wu

    期刊:BIOLOGICAL & PHARMACEUTICAL BULLETIN

    DOI:10.1248/bpb.b23-00544

    影响因子 :2.000

    引用产品:CL-0215

  • 点击展开收起列表
丁莎/胡文君

丁莎/胡文君

【 上海 】

凌晶

凌晶

【 陕西 】

朱莎莉

朱莎莉

【 湖北、河南 】

刘本佳

刘本佳

【 江苏、安徽 】

章臣雄

章臣雄

【 广东、云南 】

閤春喜

閤春喜

【 四川、甘肃、西藏 】

田博浩

田博浩

【 重庆、吉林 】

石文平

石文平

【 北京、黑龙江、辽宁 】

任施博

任施博

【 江西、福建、新疆、海南 】

李荣枫

李荣枫

【 天津、河北、内蒙古、山西 】

陈雨兰

陈雨兰

【 湖南、山东、宁夏、青海 】

尹国文

尹国文

【浙江、广西、贵州】

微信扫一扫咨询

微信扫一扫咨询

在线客服
关闭
在线咨询
联系销售

关注微信公众号